ARCHIVES

Sen. Specter Seeks NCI Explanation of Delay in P-4 Breast Cancer Prevention Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 20 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

NSABP Accrual Slow, But Auditing Called “Impressive”

January 20, 1995

NCAB Approved NTP Transfer To NIEHS But Without Much Enthusiasm

May 30, 1980

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

New Regimens May Benefit Multiple Myeloma Patients

January 28, 2005